High-Amylose Sodium Carboxymethyl Starch Matrices: Development and Characterization of Tramadol Hydrochloride Sustained-Release Tablets for Oral Administration

<table>Cumulative % of tramadol hydrochloride released<i> in vitro</i> from once-daily commercial formulations (<svg height="9.5375004" id="M13" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 11.8875 9.5375004" width="11.8875" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,9.475)"><path d="M627 0h-562v554h562v-554z" id="x25A0"></path></g>
</svg>: Tridural 100 mg, ▲: Tridural 200 mg, ◆: Ralivia 200 mg, and ●: Zytram XL 200 mg).</table>

International Scholarly Research Notices

fig2

Figure 2

Figure 2: High-Amylose Sodium Carboxymethyl Starch Matrices: Development and Characterization of Tramadol Hydrochloride Sustained-Release Tablets for Oral Administration 

Figure 2 | High-Amylose Sodium Carboxymethyl Starch Matrices: Development and Characterization of Tramadol Hydrochloride Sustained-Release Tablets for Oral Administration 